Enhanced Proteolysis of Thiopurine S-methyltransferase (TPMT) Encoded by Mutant Alleles in Humans (TPMT3A, TPMT2): Mechanisms for the Genetic Polymorphism of TPMT Activity by Tai, Hung-Liang, Krynetski, Eugene Y., Schuetz, Erin G., Yanishevski, Yuri, Evans, William E.

Get full text

A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemia by PANETTA, John Carl, YANISHEVSKI, Yuri, PUI, Ching-Hon, SANDLUND, John T, RUBNITZ, Jeffrey, RIVERA, Gaston K, RIBEIRO, Raul, EVANS, William E, RELLING, Mary V

Get full text

Differences in Folylpolyglutamate Synthetase and Dihydrofolate Reductase Expression in Human B-Lineage versus T-Lineage Leukemic Lymphoblasts: Mechanisms for Lineage Differences in... by Galpin, A J, Schuetz, J D, Masson, E, Yanishevski, Y, Synold, T W, Barredo, J C, Pui, C H, Relling, M V, Evans, W E

Get full text

Prevalence and Growth Characteristics of Malignant Stem Cells in B-Lineage Acute Lymphoblastic Leukemia by Nishigaki, Hikari, Ito, Chikako, Manabe, Atsushi, Kumagai, Masa-aki, Coustan-Smith, Elaine, Yanishevski, Yuri, Behm, Frederick G., Raimondi, Susana C., Pui, Ching-Hon, Campana, Dario

Get full text

Reduced Folate Carrier Expression in Acute Lymphoblastic Leukemia: A Mechanism for Ploidy but not Lineage Differences in Methotrexate Accumulation by Belkov, Vladimir M., Krynetski, Eugene Y., Schuetz, John D., Yanishevski, Yuri, Masson, Eric, Mathew, Susan, Raimondi, Susana, Pui, Ching-Hon, Relling, Mary V., Evans, William E.

Get full text

In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor by UCKUN, F. M, RAMA KRISHNA NARLA, GUNTHER, R, EVANS, W, ZEREN, T, YANISHEVSKI, Yu, MYERS, D. E, WAURZYNIAK, B, EK, O, SCHNEIDER, E, MESSINGER, Y, CHELSTROM, L. M

Get full text

In vivo toxicity, pharmacokinetics, and antileukemic activity of TXU (anti-CD7)-pokeweed antiviral protein immunotoxin by WAURZYNIAK, B, SCHNEIDER, E. A, EK, O, ZEREN, T, LANGLIE, M.-C, EVANS, W. E, UCKUN, F. M, TUMER, N, YANISHEVSKI, Yu, GUNTHER, R, CHELSTROM, L. M, WENDORF, H, MYERS, D. E, IRVIN, J. D, MESSINGER, Y

Get full text

Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia by NISHIGAKI, H, ITO, C, MANABE, A, KUMAGAI, M.-A, COUSTAN-SMITH, E, YANISHEVSKI, Y, BEHM, F. G, RAIMONDI, S. C, PUI, C.-H, CAMPANA, D

Get full text

Pharmacokinetic features, immunogenicity, and toxicity of B43(anti-CD19)-pokeweed antiviral protein immunotoxin in cynomolgus monkeys by UCKUN, F. M, YANISHEVSKI, Y, LANGLIE, M.-C, IRVIN, J. D, MYERS, D. E, FULLER, G. B, EVANS, W, GUNTHER, R, TUMER, N, WAURZYNIAK, B, MESSINGER, Y, CHELSTROM, L. M, LISOWSKI, E. A, EK, O, ZEREN, T, WENDORF, H

Get full text

In vivo toxicity and pharmacokinetic features of B43 (anti-CD19)-genistein immunoconjugate in nonhuman primates by MESSINGER, Y, YANISHEVSKI, Y, EVANS, W, UCKUN, F. M, EK, O, ZEREN, T, WAURZYNIAK, B, GUNTHER, R, CHELSTROM, L, CHANDAN-LANGLIE, M, SCHNEIDER, E, MYERS, D. E

Get full text

In vivo biotherapy of HL-60 myeloid leukemia with a genetically engineered recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulating factor rece... by PERENTESIS, J. P, GUNTHER, R, EVANS, W. E, UCKUN, F. M, WAURZYNIAK, B, YANISHEVSKI, Y, MYERS, D. E, EK, O, MESSINGER, Y, SHAO, Y, CHELSTROM, L. M, SCHNEIDER, E

Get full text

Enhanced proteolysis of thiopurine S-methyltranferase (TPMT) encoded by mutant alleles in humans (TPMT3A, TPMT2): Mechanims for the genetic polymorphism of TPMT activity by Tai, Hung-Liang, Krynetski, Eugene Y, Schuetz, Erin G, Yanishevski, Yuri, Evans, William E

Get full text

Reduced folate carrier expression in acute lymphoblastic leukemia : A mechanism for ploidy but not lineage differences in methotrexate accumulation by BELKOV, V. M, KRYNETSKI, E. Y, SCHUETZ, J. D, YANISHEVSKI, Yu, MASSON, E, MATHEW, S, RAIMONDI, S, PUI, C.-H, RELLING, M. V, EVANS, W. E

Get full text

Treatment of human B-cell precursor leukemia in SCID mice using a combination of the investigational biotherapeutic agent B43-PAP with cytosine arabinoside by MESSINGER, Y, YANISHEVSKI, Y, AVRAMIS, V. I, EK, O, CHELSTROM, L. M, GUNTHER, R, MYERS, D. E, IRVIN, J. D, EVANS, W, UCKUN, F. M

Get full text

In Vivo., Toxicity and Pharmacokinetic Features of B43(Anti-CD19)-Genistein Immunoconjugate by Ek, Onur, Yanishevskic, Yuri, Zeren, Tamer, Waurzyniak, Barbara, Gunther, Roland, Chelstrom, Lisa, Chandan-Langlie, Mridula, Schneider, Elizabeth, Myers, Dorothea E., Evans, William, Uckun, Fatih M.

Get full text